Pharma Lobby Fights Back Against Trump Criticism With TV Ads
- Plans to spend tens of millions for next few years on ads
- Trump has declared industry is ‘getting away with murder’
Trump's Stance on Drug Prices
This article is for subscribers only.
Big pharma’s lobbying arm is fighting back against outrage over rising drug costs from the public and President Donald Trump, who has the industry in his crosshairs.
The image makeover, led by the Pharmaceutical Research and Manufacturers of America Washington lobby group, includes plans to spend tens of millions of dollars annually on advertisements and public affairs efforts over the next four to five years. In a press conference Monday, Chief Executive Officer Stephen Ubl unveiled an extensive campaign to counter critics by highlighting science in drug development.